421768143	421768143	CD	B-NP	O
|	|	NN	I-NP	O
LCMC	LCMC	NN	I-NP	O
|	|	NN	I-NP	O
40173058	40173058	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1691039	1691039	CD	B-NP	O
|	|	CC	I-NP	O
8/9/2005	8/9/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/12/2005	1/12/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NN	B-NP	O
:	:	:	O	O
HOGGE	HOGGE	NN	B-NP	O
,	,	,	O	O
WILLIAMS	WILLIAMS	NNP	B-NP	O
DAREN	DAREN	NNP	I-NP	O
MD	MD	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Elective	Elective	JJ	B-NP	O
right	right	JJ	I-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
interstitial	interstitial	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
autoimmune	autoimmune	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
cirrhosis	cirrhosis	NN	B-NP	O
with	with	IN	B-PP	O
varices	varix	NNS	B-NP	O
,	,	,	O	O
hypersplenism	hypersplenism	NN	B-NP	O
and	and	CC	I-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
lived	live	VBD	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
independent	independent	JJ	B-ADJP	O
with	with	IN	B-PP	O
activities	activity	NNS	B-NP	O
of	of	IN	B-PP	O
daily	daily	JJ	B-NP	O
living	living	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Roundcleod	Roundcleod	NNP	B-NP	O
Valley	Valley	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
9/2/05	9/2/05	CD	I-NP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
right	right	JJ	I-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Migraine	Migraine	NNP	B-NP	O
headaches	headache	VBZ	B-VP	O
,	,	,	O	O
interstitial	interstitial	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
reflux	reflux	NN	B-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	B-protein
A	A	NNP	I-NP	I-protein
,	,	,	O	O
autoimmune	autoimmune	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
cirrhosis	cirrhosis	NN	B-NP	O
with	with	IN	B-PP	O
varices	varix	NNS	B-NP	O
,	,	,	O	O
hypersplenism	hypersplenism	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
,	,	,	O	O
coagulopathy	coagulopathy	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
x10	x10	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
,	,	,	O	O
osteoporosis	osteoporosis	NN	B-NP	O
,	,	,	O	O
L4	L4	NN	B-NP	O
compression	compression	NN	I-NP	O
fracture	fracture	NN	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Valium	Valium	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Advair	Advair	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Combivent	Combivent	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Propranolol	Propranolol	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Spironolactone	Spironolactone	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
cigarettes	cigarette	NNS	B-NP	O
or	or	CC	O	O
drink	drink	VB	B-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
married	marry	VBN	I-VP	O
with	with	IN	B-PP	O
four	four	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Potassium	Potassium	NN	B-NP	O
4.3	4.3	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
9.9	9.9	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
26.3	26.3	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
61	61	CD	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	O
1.3	1.3	CD	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
First	First	RB	B-VP	O
documented	document	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
team	team	NN	I-NP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
,	,	,	O	O
afebrile	afebrile	RB	B-ADVP	O
.	.	.	O	O

Pulse	Pulse	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
70s	70	NNS	I-NP	O
and	and	CC	I-NP	O
sinus	sinus	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s/50s	90s/50	NNS	I-NP	B-DNA
.	.	.	O	O

Satting	Satte	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Thin	Thin	JJ	B-NP	O
,	,	,	I-NP	O
elderly	elderly	JJ	I-NP	O
woman	woman	NN	I-NP	O
,	,	,	O	O
faint	faint	JJ	B-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NNP	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
IMAGING	IMAGING	NN	I-NP	O
:	:	:	O	O
Portable	Portable	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
10/11/05	10/11/05	CD	B-NP	O
with	with	IN	B-PP	O
patchy	patchy	JJ	B-NP	O
opacity	opacity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lung	lung	NN	I-NP	O
base	base	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
.	.	.	O	O

QTC	QTC	NN	B-NP	B-DNA
464	464	CD	I-NP	I-DNA
.	.	.	O	O

LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
T-wave	T-wave	JJ	B-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
,	,	,	O	O
T-wave	T-wave	NN	B-NP	O
flattening	flattening	NN	I-NP	O
in	in	IN	B-PP	O
AVF	AVF	NN	B-NP	B-protein
,	,	,	O	O
T-wave	T-wave	NN	B-NP	O
flattening	flattening	NN	I-NP	O
in	in	IN	B-PP	O
V3	V3	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Ortho	Ortho	NNP	B-NP	O
:	:	:	O	O
Right	Right	NN	B-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
uncomplicated	uncomplicated	JJ	I-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
her	her	PRP$	B-NP	O
leg	leg	NN	I-NP	O
was	be	VBD	B-VP	O
immobilized	immobilize	VBN	I-VP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
orthopedic	orthopedic	JJ	B-NP	O
recommendations	recommendation	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
reason	reason	NN	I-NP	O
for	for	IN	B-PP	O
immobilization	immobilization	NN	B-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
movement	movement	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
might	might	MD	B-VP	O
precipitate	precipitate	VB	I-VP	O
skin	skin	NN	B-NP	O
tears	tear	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
incurred	incur	VBD	B-VP	O
a	a	DT	B-NP	O
laceration	laceration	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
calf	calf	NN	I-NP	O
perioperatively	perioperatively	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
incurred	incur	VBD	B-VP	O
a	a	DT	B-NP	O
skin	skin	NN	I-NP	O
tear	tear	NN	I-NP	O
on	on	IN	B-PP	O
11/29/05	11/29/05	CD	B-NP	O
with	with	IN	B-PP	O
turning	turn	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
skin	skin	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
paper	paper	NN	B-NP	O
thin	thin	JJ	B-ADJP	O
with	with	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
fluid	fluid	NN	B-NP	O
.	.	.	O	O

Wound	Wound	JJ	B-NP	O
healing	healing	NN	I-NP	O
was	be	VBD	B-VP	O
impaired	impair	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
albumin	albumin	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
steroid	steroid	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Plastic	Plastic	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
team	team	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
appropriate	appropriate	JJ	B-NP	O
dressings	dressing	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
skin	skin	NN	I-NP	O
tears	tear	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
team	team	NN	I-NP	O
also	also	RB	B-ADVP	O
grafted	graft	VBD	B-VP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
skin	skin	NN	I-NP	O
tear	tear	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
supplemental	supplemental	JJ	B-NP	O
vitamins	vitamin	NNS	I-NP	O
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
wound	wound	NN	B-NP	O
healing	healing	NN	I-NP	O
including	include	VBG	B-PP	O
vitamin	vitamin	NN	B-NP	O
A	A	NN	I-NP	O
and	and	CC	I-NP	O
zinc	zinc	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
skin	skin	NN	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

Originally	Originally	RB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complete	complete	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
Keflex	Keflex	NNP	B-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
versus	versus	CC	I-NP	O
skin	skin	NN	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
End	End	NN	B-NP	O
stage	stage	NN	I-NP	O
liver	liver	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
varices	varix	NNS	B-NP	O
and	and	CC	I-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
complete	complete	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
panel	panel	NN	I-NP	O
and	and	CC	I-NP	O
coags	coag	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
transaminases	transaminase	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
alkaline	alkaline	NN	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
trended	trend	VBD	B-VP	O
upward	upward	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
reported	report	VBD	B-VP	O
was	be	VBD	B-VP	O
chronic	chronic	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
5/13/05	5/13/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
her	her	PRP	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
and	and	CC	O	O
elevated	elevated	JJ	B-NP	O
alk/phos	alk/pho	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
2.0	2.0	CD	I-NP	O
x	x	SYM	I-NP	O
1.6	1.6	CD	I-NP	O
x	x	SYM	I-NP	O
1.6	1.6	CD	I-NP	O
cm	cm	NN	I-NP	O
hyperechoic	hyperechoic	JJ	I-NP	O
mass	mass	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
portahepatis	portahepatis	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
cirrhosis	cirrhosis	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
common	common	JJ	B-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
dilation	dilation	NN	I-NP	O
and	and	CC	I-NP	O
splenomegaly	splenomegaly	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
portahepatic	portahepatic	JJ	I-NP	O
mass	mass	NN	I-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
autoimmune	autoimmune	JJ	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
varices	varix	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
propranolol	propranolol	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	I-NP	O
spironolactone	spironolactone	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
through	through	IN	B-PP	O
much	much	JJ	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/19/05	6/19/05	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
remedy	remedy	VB	I-VP	O
her	her	PRP$	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Low	Low	JJ	B-NP	O
albumin	albumin	NN	I-NP	O
state	state	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
prealbumin	prealbumin	NN	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
PO	PO	NN	I-NP	O
intake	intake	NN	I-NP	O
versus	versus	CC	O	O
decreased	decrease	VBD	B-VP	O
synthetic	synthetic	JJ	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
wasting	waste	VBG	I-VP	O
protein	protein	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
refused	refuse	VBD	B-VP	O
?	?	.	O	O
?	?	.	O	O
___	___	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
placement	placement	NN	B-NP	O
for	for	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
house	house	NN	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
Ensure	Ensure	NN	B-NP	O
and	and	CC	I-NP	O
Boost	Boost	NN	I-NP	O
supplements	supplement	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
MVI	MVI	NN	B-NP	O
and	and	CC	I-NP	O
lactinex	lactinex	NN	I-NP	O
granules	granule	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
taking	take	VBG	I-VP	O
in	in	RP	B-PRT	O
adequate	adequate	JJ	B-NP	O
calories	calorie	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/19/05	6/19/05	CD	B-NP	O
,	,	,	O	O
TPN	TPN	NN	B-NP	B-protein
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Persistent	Persistent	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
studies	study	NNS	I-NP	O
including	include	VBG	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NN	I-NP	O
testing	testing	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
celiac	celiac	JJ	B-NP	O
sprue	sprue	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
testing	testing	NN	I-NP	O
,	,	,	O	O
too	too	RB	B-ADVP	O
,	,	,	O	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
symptomatically	symptomatically	RB	B-ADVP	O
with	with	IN	B-PP	O
Imodium	Imodium	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GERD	GERD	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
and	and	CC	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
Maalox	Maalox	NNP	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Dysphagia	Dysphagia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
trouble	trouble	NN	B-NP	O
swallowing	swallow	VBG	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Speech	Speech	NNP	I-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NNP	I-NP	O
team	team	NN	I-NP	O
on	on	IN	B-PP	O
4/6/05	4/6/05	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
swallowing	swallow	VBG	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
Postoperative	Postoperative	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
:	:	:	O	O
Immediately	Immediately	RB	B-ADVP	O
postoperatively	postoperatively	RB	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
versus	versus	CC	O	O
perioperative	perioperative	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Skin	Skin	NNP	B-NP	O
Prophylaxis	Prophylaxis	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	O	O
switched	switch	VBN	B-VP	O
to	to	TO	B-PP	O
Keflex	Keflex	NNP	B-NP	O
.	.	.	O	O

Urinary	Urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
dirty	dirty	JJ	B-NP	O
UA	UA	NNP	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
urine	urine	NN	I-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
that	that	WDT	B-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
resistant	resistant	JJ	B-NP	O
staph	staph	NN	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
finished	finish	VBD	B-VP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
on	on	IN	B-PP	O
8/7/05	8/7/05	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
UA	UA	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

Odynophagia	Odynophagia	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
trouble	trouble	NN	B-NP	O
swallowing	swallow	VBG	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
empirically	empirically	RB	B-ADVP	O
with	with	IN	B-PP	O
fluconazole	fluconazole	NN	B-NP	O
and	and	CC	I-NP	O
clotrimazole	clotrimazole	NN	I-NP	O
for	for	IN	B-PP	O
esophageal	esophageal	JJ	B-NP	O
Candida	Candida	NNP	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
treatment	treatment	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
remedy	remedy	VB	I-VP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
swallowing	swallow	VBG	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
mouth	mouth	NN	B-NP	O
sores	sore	NNS	I-NP	O
.	.	.	O	O

HSV	HSV	NN	B-NP	B-protein
swabs	swab	NNS	I-NP	I-protein
of	of	IN	B-PP	O
these	these	DT	B-NP	O
sores	sore	NNS	I-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
symptomatically	symptomatically	RB	B-ADVP	O
with	with	IN	B-PP	O
viscous	viscous	JJ	B-NP	O
lidocaine	lidocaine	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
interstitial	interstitial	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
asthma	asthma	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Combivent	Combivent	NNP	B-NP	O
and	and	CC	O	O
standing	stand	VBG	B-VP	O
nebulizer	nebulizer	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
8/6/05	8/6/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Differential	Differential	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
was	be	VBD	B-VP	O
PE	PE	NN	B-NP	O
versus	versus	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
versus	versus	CC	I-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
8/6/05	8/6/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
left	left	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
10/17/05	10/17/05	CD	B-NP	O
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
7/15/05	7/15/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Pain	Pain	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
standing	stand	VBG	B-VP	O
codeine	codeine	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
.	.	.	O	O

Nausea	Nausea	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
Compazine	Compazine	NNP	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Pump	Pump	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
intravascularly	intravascularly	RB	I-VP	O
depleted	deplete	VBN	I-VP	O
as	as	IN	B-SBAR	O
evidenced	evidence	VBN	B-VP	O
by	by	IN	B-PP	O
prerenal	prerenal	JJ	B-NP	O
urine	urine	NN	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
low	low	JJ	I-NP	O
albumin	albumin	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
third-spacing	third-spacing	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
intermittently	intermittently	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
and	and	CC	I-NP	O
spa	spa	NN	I-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
6/19/05	6/19/05	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
spa	spa	NN	B-NP	B-protein
in	in	IN	B-PP	O
conjunction	conjunction	NN	B-NP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
markers	marker	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
had	have	VBD	B-VP	O
nonspecific	nonspecific	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
aspirin	aspirin	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Decreased	Decrease	VBN	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
onward	onward	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
relative	relative	JJ	B-NP	O
oliguria	oliguria	NN	I-NP	O
,	,	,	O	O
500	500	CD	B-NP	O
to	to	TO	I-NP	O
900	900	CD	I-NP	O
cc	cc	NN	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
approximately	approximately	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
trended	trend	VBD	B-VP	O
downward	downward	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
as	as	RB	B-ADVP	O
low	low	JJ	I-ADVP	O
as	as	IN	B-PP	O
0.2	0.2	CD	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
intermittently	intermittently	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
and	and	CC	I-NP	O
spa	spa	NN	I-NP	B-protein
versus	versus	CC	I-NP	O
spa	spa	NN	I-NP	B-protein
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Hyponatremia	Hyponatremia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
fluid	fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/19/05	6/19/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
spa	spa	NN	I-NP	B-protein
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
,	,	,	I-NP	O
cortisol	cortisol	NN	I-NP	O
and	and	CC	I-NP	O
uric	uric	JJ	I-NP	O
acid	acid	NN	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
other	other	JJ	B-NP	O
etiologies	etiology	NNS	I-NP	O
of	of	IN	B-PP	O
hyponatremia	hyponatremia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
steroid	steroid	NN	B-NP	O
induced	induced	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
and	and	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NNP	B-NP	B-protein
:	:	:	O	O
Anemia	Anemia	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
iron	iron	NN	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
and	and	CC	I-NP	O
folate	folate	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Thrombocytopenia	Thrombocytopenia	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
splenic	splenic	JJ	B-NP	O
sequestration	sequestration	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
antiplatelet	antiplatelet	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Anticoagulation	Anticoagulation	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
indications	indication	NNS	I-NP	O
for	for	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
was	be	VBD	B-VP	O
right	right	JJ	B-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
second	second	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
superficial	superficial	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
DVT	DVT	NN	I-NP	O
discovered	discover	VBN	B-VP	O
on	on	IN	B-PP	O
10/16/05	10/16/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
1.5	1.5	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
risk	risk	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
INR	INR	NN	I-NP	B-protein
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
known	known	JJ	I-NP	O
varices	varix	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
8/21/05	8/21/05	CD	B-NP	O
onward	onward	RB	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
supertherapeutic	supertherapeutic	JJ	B-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
supertherapeutic	supertherapeutic	JJ	I-NP	O
INR	INR	NN	I-NP	O
could	could	MD	B-VP	O
relate	relate	VB	I-VP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
effects	effect	NNS	I-NP	O
versus	versus	IN	B-PP	O
nutritional	nutritional	JJ	B-NP	O
deficiencies	deficiency	NNS	I-NP	O
versus	versus	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
Osteoporosis	Osteoporosis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
cholecalciferol	cholecalciferol	NN	B-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Physical	Physical	JJ	I-NP	O
Therapy	Therapy	NN	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Access	Access	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PIC	PIC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	I-NP	O
disposition	disposition	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
dictated	dictate	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Steven	Steven	NNP	I-NP	O
Jaksic	Jaksic	NNP	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-9937431	2-9937431	CD	B-NP	O
OCA	OCA	NNP	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
HEPA	HEPA	NNP	B-NP	O
,	,	,	O	O
SETH	SETH	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DEGRELLA	DEGRELLA	NNP	B-NP	O
,	,	,	O	O
HERSHEL	HERSHEL	NNP	B-NP	O
GARRY	GARRY	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1965140	1965140	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/10/05	4/10/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/10/05	4/10/05	CD	B-NP	O

